Aegon, Allianz Solvency II ratios diverge under coronavirus stress
Whipsawing markets roiled the asset portfolios of both Aegon and Allianz in the first quarter. But the former found its capital ratio was largely shielded from adverse effects by regulatory relief measures, a benefit not evident at the latter.
Aegon’s Solvency II ratio, the proportion of loss-absorbing own-funds to its solvency capital requirement (SCR), actually increased over the first three months of the year by seven percentage points to 208%. The insurer said the application of the
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Risk Quantum
Derivatives
GFXC confirms zero hold times in last look
Chair says checks can’t be used to monitor client market impact – a “game changer” according to some
Receive this by email